LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors
- PMID: 9287142
- DOI: 10.1089/hum.1997.8.12-1417
LacZ and interleukin-3 expression in vivo after retroviral transduction of marrow-derived human osteogenic mesenchymal progenitors
Abstract
Human marrow-derived mesenchymal progenitor cells (hMPCs), which have the capacity for osteogenic and marrow stromal differentiation, were transduced with the myeloproliferative sarcoma virus (MPSV)-based retrovirus, vM5LacZ, that contains the LacZ and neo genes. Stable transduction and gene expression occurred in 18% of cells. After culture expansion and selection in G418, approximately 70% of neo(r) hMPCs co-expressed LacZ. G418-selected hMPC retain their osteogenic potential and form bone in vivo when seeded into porous calcium phosphate ceramic cubes implanted subcutaneously into SCID mice. LacZ expression was evident within osteoblasts and osteocytes in bone developing within the ceramics 6 and 9 weeks after implantation. Likewise, hMPCs transduced with human interleukin-3 (hIL-3) cDNA, adhered to ceramic cubes and implanted into SCID mice, formed bone and secreted detectable levels of hIL-3 into the systemic circulation for at least 12 weeks. These data indicate that genetically transduced, culture-expanded bone marrow-derived hMPCs retain a precursor phenotype and maintain similar levels of transgene expression during osteogenic lineage commitment and differentiation in vivo. Because MPCs have been shown to differentiate into bone, cartilage, and tendon, these cells may be a useful target for gene therapy.
Similar articles
-
Selection, enrichment, and culture expansion of murine mesenchymal progenitor cells by retroviral transduction of cycling adherent bone marrow cells.Exp Hematol. 2000 Dec;28(12):1460-9. doi: 10.1016/s0301-472x(00)00551-8. Exp Hematol. 2000. PMID: 11146168
-
Human mesenchymal stem cells maintain transgene expression during expansion and differentiation.Mol Ther. 2001 Jun;3(6):857-66. doi: 10.1006/mthe.2001.0327. Mol Ther. 2001. PMID: 11407899
-
Myeloproliferative sarcoma virus directed expression of beta-galactosidase following retroviral transduction of murine hematopoietic cells.Exp Hematol. 1995 Jul;23(7):630-8. Exp Hematol. 1995. PMID: 7601255
-
Stem cell technology and bioceramics: from cell to gene engineering.J Biomed Mater Res. 1999;48(6):913-27. doi: 10.1002/(sici)1097-4636(1999)48:6<913::aid-jbm22>3.0.co;2-0. J Biomed Mater Res. 1999. PMID: 10556859 Review.
-
Osteogenic stem-cell characterization and development: potentials for cytotherapy.Cytotherapy. 2001;3(5):413-6. doi: 10.1080/146532401753277760. Cytotherapy. 2001. PMID: 11953025 Review.
Cited by
-
Genetically engineered immune privileged Sertoli cells: A new road to cell based gene therapy.Spermatogenesis. 2012 Jan 1;2(1):23-31. doi: 10.4161/spmg.19119. Spermatogenesis. 2012. PMID: 22553487 Free PMC article.
-
Defining human mesenchymal stem cell efficacy in vivo.J Inflamm (Lond). 2010 Oct 25;7:51. doi: 10.1186/1476-9255-7-51. J Inflamm (Lond). 2010. PMID: 20974000 Free PMC article.
-
Epidermal growth factor (EGF) transfection of human bone marrow stromal cells in bone tissue engineering.J Cell Mol Med. 2009 Aug;13(8B):2593-2601. doi: 10.1111/j.1582-4934.2008.00600.x. J Cell Mol Med. 2009. PMID: 19067768 Free PMC article.
-
Use of tissue engineering strategies to repair joint tissues in osteoarthritis: viral gene transfer approaches.Curr Rheumatol Rep. 2014 Oct;16(10):449. doi: 10.1007/s11926-014-0449-0. Curr Rheumatol Rep. 2014. PMID: 25182677 Review.
-
Adenovector-mediated gene delivery to human umbilical cord mesenchymal stromal cells induces inner ear cell phenotype.Cell Reprogram. 2013 Feb;15(1):43-54. doi: 10.1089/cell.2011.0097. Cell Reprogram. 2013. PMID: 23379581 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources